Long M, Allegretti JR, Danese S, Germinaro M, et al. Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trial. Lancet Gastroenterol Hepatol 2026 Jan 13:S2468-1253(25)00322.
PMID: 41544637